9 METERS BIOPHARMA INC (NMTR)
US6544052086 - Common Stock
| TTM (2023-3-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | 2020 (2020-12-31) | 2019 (2019-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| CASH FLOWS FROM OPERATING ACTIVITIES | ||||||||
| Net Income | -46.28M | -43.77M | -36.78M | -61.50M | -27.05M | |||
| Depreciation Amortization | 8.22K | 8.52K | 7.57K | 20.00K | 20.00K | |||
| Change In Working Capital | 2.06M | 661.42K | 2.23M | 780.00K | 3.89M | |||
| Interest Paid | 1.01M | 835.04K | 570.00 | 60.00K | 870.00K | |||
| Taxes Paid | N/A | N/A | N/A | N/A | N/A | |||
| Other non cash items | 6.97M | 5.85M | 5.06M | 41.29M | 5.16M | |||
| OPERATING CASH FLOW | -37.24M | -37.24M | -29.48M | -19.41M | -17.97M | |||
| CASH FLOWS FROM INVESTING ACTIVITIES | ||||||||
| Capital Expenditure | 0.00 | -2.84K | -12.48K | 0.00 | -10.00K | |||
| Other Investing Activity | N/A | 0.00 | -2.42M | -3.18M | 0.00 | |||
| INVESTING CASH FLOW | 0.00 | -2.84K | -2.43M | -3.19M | -10.00K | |||
| CASH FLOWS FROM FINANCING ACTIVITIES | ||||||||
| Debt Issued/Reduced | 4.25M | 21.00M | -58.20K | 40.00K | -2.79M | |||
| Stock Issued/Repurchased | 5.00M | 0.00 | 44.01M | 62.24M | 20.74M | |||
| Other Financing Activity | N/A | -1.09M | -2.90M | -6.42M | -1.10M | |||
| FINANCING CASH FLOW | 7.63M | 19.91M | 41.05M | 55.86M | 16.84M | |||
| CHANGE IN CASH | -29.62M | -17.33M | 9.14M | 33.26M | -1.14M | |||
| FREE CASH FLOW | ||||||||
| Operating Cash Flow | -37.24M | -37.24M | -29.48M | -19.41M | -17.97M | |||
| Capital Expenditure | 0.00 | -2.84K | -12.48K | 0.00 | -10.00K | |||
| FREE CASH FLOW | -37.24M | -37.25M | -29.49M | -19.41M | -17.98M | |||
All data in USD